Publication | Open Access

The Effects of NLY01, a Novel Glucagon-Like Peptide-1 Receptor Agonist, on Cuprizone-Induced Demyelination and Remyelination: Challenges and Future Perspectives

Future PerspectivesMedicineImmunologyPharmacologyCuprizone-induced DemyelinationNeuropharmacologyNeurologyMolecular NeurobiologyNeuroimmunologyNeuroinflammation